研究单位：[1]Allergan[2]Tigermed Consulting Co., Ltd[3]Peking University First Hospital,Beijing,China,100034[4]People's Hospital of Peking University,Beijing,China,100044[5]Beijing Friendship Hospital of Capital Medical University,Beijing,China,100050[6]Beijing Hospital,Beijing,China,100730[7]Beijing TongRen Hospital,Beijing,China,100730[8]Peking Union Medical College Hospital,Beijing,China,100730[9]Zhongshan Ophthalmic Center, Sun Yet-Sen University,Guangzhou,Guangdong,China,510060[10]Renmin Hospital of Wuhan University,Wuhan,Hubei,China,430060[11]The Second Xiangya Hospital of Central South University,Changsha,Hunan,China,410011[12]The First Hospital of Nanjing Medical University,Nanjing,Jiangsu,China,210029[13]The 2nd hospital of JiLin University,Changchun,Jilin,China,130041[14]The Eye and ENT Hospital, Affiliated of Fudan University,Shanghai,Shanghai,China,200031[15]West China Hospital, Sichuan University,Chengdu,Sichuan,China,610041[16]Tianjin Eye Hospital,Tianjin,China,300020[17]TianJin Medical University Eye Hospital,Tianjin,China,300384[18]Wenzhou Ophthalmic Centre,Wenzhou,Zhejiang,China,325027[19]Asian Eye Institute,Makati City,Metro Manila,Philippines,1200[20]Peregrine Eye and Laser Institute,Makati City,Metro Manila,Philippines,1209
研究目的：
This study will evaluate the safety and efficacy of 700 μg dexamethasone versus laser photocoagulation in participants with diabetic macular edema (DME).
